Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Nov 15;1(2):136-46.
Print 2012.

Anti-cytokine autoantibodies in autoimmune diseases

Giuseppe Cappellano  1 , Elisabetta Orilieri, Abiy D Woldetsadik, Elena Boggio, Maria F Soluri, Cristoforo Comi, Daniele Sblattero, Annalisa Chiocchetti, Umberto Dianzani
Affiliations

Anti-cytokine autoantibodies in autoimmune diseases

Giuseppe Cappellano et al. Am J Clin Exp Immunol. .

Abstract

An overview of the current literature is showing that autoantibodies (AutoAbs) against cytokines are produced in several pathological conditions, including autoimmune diseases, but can also be detected in healthy individuals. In autoimmune diseases, these AutoAbs may also be prognostic markers, either negative (such as AutoAbs to IL-8 and IL-1α in rheumatoid arthritis) or positive (such as AutoAbs to IL-6 in systemic sclerosis and those to osteopontin in rheumatoid arthritis). They may have neutralizing activity and influence the course of the physiological and pathological immune responses. High levels of AutoAbs against cytokines may even lead to immunodeficiency, such as those to IL-17 in autoimmune polyendocrine syndrome type I or those to IFN-γ in mycobacterial infections. Their role in human therapy may be exploited not only through passive immunization but also through vaccination, which may improve the costs for long lasting treatments of autoimmune diseases. Detection and quantification of these AutoAbs can be profoundly influenced by the technique used and standardization of these methods is needed to increase the value of their analysis.

Keywords: Cytokines; autoantibodies; autoimmune diseases; vaccines.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Number of publications focused on AutoAbs against cytokines between 1975 and 2011 (http://www.ncbi.nlm.nih.gov/pubmed/).
See this image and copyright information in PMC

References

    1. Kearney JF. Formation of autoantibodies, including anti-cytokine antibodies, is a hallmark of the immune response of early B cells. J Interferon Res. 1994;14:151–152. - PubMed
    1. Özen S, Berk Ö, Şimşek DG, Darcan S. Clinical course of Hashimoto’s thyroiditis and effects of levothyroxine therapy on the clinical course of the disease in children and adolescents. J Clin Res Pediatr Endocrinol. 2011;3:192–197. - PMC - PubMed
    1. McKee A, Peyerl F. TSI assay utilization: impact on costs of Graves’hyperthyroidism diagnosis. Am J Manag Care. 2012;18:e1–14. - PubMed
    1. Sblattero D, Berti I, Trevisiol C, Marzari R, Tommasini A, Bradbury A, Fasano A, Ventura A, Not T. Human recombinant tissue transglutaminase ELISA: an innovative diagnostic assay for celiac disease. Am J Gastroenterol. 2000;95:1253–1257. - PubMed
    1. Slavikova M, Schmeisser H, Kontsekova E, Mateicka F, Borecky L, Kontsek P. Incidence of autoantibodies against type I and type II interferons in a cohort of systemic lupus erythematosus patients in Slovakia. J Interferon Cytokine Res. 2003;23:143–147. - PubMed

LinkOut - more resources